Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)
Completed
Mahidol University
Phase 4
2005-09-01
The purpose of this study is to determine whether etoricoxib, flavoxate, both are effective
in the treatment postoperative pain after TURP.
The research hypothesis:
There is a difference in postoperative morphine consumption in the first 24 hours after
transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and
placebo.
A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions
Completed
Padagis LLC
Phase 1
1969-12-31
The purpose of this study is to compare the relative bioavailability of Flavoxate
Hydrochloride tablets 100mg manufactured by Paddock Laboratories, Inc., with that of Urispas®
tablets 100mg by SmithKline Beecham Pharmaceuticals under fasting conditions.
A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions
Completed
Paddock Laboratories, Inc.
Phase 1
1969-12-31
The purpose of this study is to compare the relative bioavailability of Flavoxate
Hydrochloride tablets 100mg manufactured by Paddock Laboratories, Inc., with that of Urispas®
tablets 100mg by SmithKline Beecham Pharmaceuticals under fasting conditions.
The primary goal of this study is to determine if the addition of the bladder antispasmotic
oxybutynin to standard antimicrobial therapy in the treatment of childhood cystitis will
decrease the associated pain and discomfort. A randomized, double blind, placebo-controlled
clinical trial design will be used. The second goal of this study will be to describe the
nature and duration of symptoms associated with uncomplicated cystitis in the paediatric age
group. Finally, adverse side effects associated with short term use of oxybutynin will be
monitored.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
